Djillali Annane to Survival Analysis
This is a "connection" page, showing publications Djillali Annane has written about Survival Analysis.
Connection Strength
0.248
-
Targeting skeletal muscle tissue oxygenation (StO2) in adults with severe sepsis and septic shock: a randomised controlled trial (OTO-StS Study). BMJ Open. 2018 03 19; 8(3):e017581.
Score: 0.068
-
Hydrocortisone plus Fludrocortisone for Adults with Septic Shock. N Engl J Med. 2018 Mar 01; 378(9):809-818.
Score: 0.068
-
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. N Engl J Med. 2021 Aug 26; 385(9):790-802.
Score: 0.021
-
Population pharmacokinetics of lopinavir/ritonavir in Covid-19 patients. Eur J Clin Pharmacol. 2021 Mar; 77(3):389-397.
Score: 0.020
-
Impact of medical care, including use of anti-infective agents, on prognosis of COVID-19 hospitalized patients over time. Int J Antimicrob Agents. 2020 Oct; 56(4):106129.
Score: 0.020
-
Timing of Renal-Replacement Therapy in Patients with Acute Kidney Injury and Sepsis. N Engl J Med. 2018 Oct 11; 379(15):1431-1442.
Score: 0.018
-
Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. Lancet Infect Dis. 2018 01; 18(1):95-107.
Score: 0.016
-
Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev. 2017 10 06; 10:CD004427.
Score: 0.016